APO Research
Talk to an analyst

APO RESEARCH · REPORT

Red Blood Cell Products

Compare research editions
View pricing & licenses

Selected research

Industry Research

Red Blood Cell Products Industry Research Report 2026

23 December 2025151 pages

Choose your research edition.

Industry ResearchRed Blood Cell Products Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Red Blood Cell Products Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Red Blood Cell Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Red Blood Cell Products Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Red Blood Cell Products Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Red Blood Cell Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Red Blood Cell Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Red Blood Cell Products is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Red Blood Cell Products is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Red Blood Cell Products include China National Biotec Group, Weiguang Biological, Tiantan Biological, Shanghai RAAS Blood Products, Pilin Biological, Hualan Biological, Boyaa Bio-pharmaceutical, Bohui Innovation and Takeda Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Red Blood Cell Products market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Red Blood Cell Products Market by Company

China National Biotec Group

Weiguang Biological

Tiantan Biological

Shanghai RAAS Blood Products

Pilin Biological

Hualan Biological

Boyaa Bio-pharmaceutical

Bohui Innovation

Takeda Pharmaceutical

Sangamo Therapeutics

Octapharma

LFB Group

Kedrion

Kamada

Hemophilia Federation Europe

Grifols

Emergent BioSolutions

CSL Behring

Biotest

American Red Cross

Red Blood Cell Products Segment by Type

Washed Red Blood Cells

Concentrated Red Blood Cells

Frozen Red Blood Cells

Red Blood Cell Suspension

Irradiated Red Blood Cells

Others

Red Blood Cell Products Segment by Application

Blood Disease Supportive Treatment

Special Disease Management

Anemia Treatment

Acute Hemorrhage

Red Blood Cell Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Red Blood Cell Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Red Blood Cell Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Red Blood Cell Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Red Blood Cell Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Red Blood Cell Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Red Blood Cell Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Red Blood Cell Products Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Red Blood Cell Products Sales (units) of Manufacturers (2021-2026) Table 7. Global Red Blood Cell Products Sales Market Share by Manufacturers (2021-2026) Table 8. Global Red Blood Cell Products Revenue of Manufacturers (2021-2026) Table 9. Global Red Blood Cell Products Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Red Blood Cell Products Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Red Blood Cell Products Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Red Blood Cell Products, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Red Blood Cell Products, Product Type & Application Table 14. Global Red Blood Cell Products Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Red Blood Cell Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. China National Biotec Group Company Information Table 19. China National Biotec Group Business Overview Table 20. China National Biotec Group Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. China National Biotec Group Red Blood Cell Products Product Portfolio Table 22. China National Biotec Group Recent Developments Table 23. Weiguang Biological Company Information Table 24. Weiguang Biological Business Overview Table 25. Weiguang Biological Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Weiguang Biological Red Blood Cell Products Product Portfolio Table 27. Weiguang Biological Recent Developments Table 28. Tiantan Biological Company Information Table 29. Tiantan Biological Business Overview Table 30. Tiantan Biological Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Tiantan Biological Red Blood Cell Products Product Portfolio Table 32. Tiantan Biological Recent Developments Table 33. Shanghai RAAS Blood Products Company Information Table 34. Shanghai RAAS Blood Products Business Overview Table 35. Shanghai RAAS Blood Products Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Shanghai RAAS Blood Products Red Blood Cell Products Product Portfolio Table 37. Shanghai RAAS Blood Products Recent Developments Table 38. Pilin Biological Company Information Table 39. Pilin Biological Business Overview Table 40. Pilin Biological Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Pilin Biological Red Blood Cell Products Product Portfolio Table 42. Pilin Biological Recent Developments Table 43. Hualan Biological Company Information Table 44. Hualan Biological Business Overview Table 45. Hualan Biological Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Hualan Biological Red Blood Cell Products Product Portfolio Table 47. Hualan Biological Recent Developments Table 48. Boyaa Bio-pharmaceutical Company Information Table 49. Boyaa Bio-pharmaceutical Business Overview Table 50. Boyaa Bio-pharmaceutical Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Boyaa Bio-pharmaceutical Red Blood Cell Products Product Portfolio Table 52. Boyaa Bio-pharmaceutical Recent Developments Table 53. Bohui Innovation Company Information Table 54. Bohui Innovation Business Overview Table 55. Bohui Innovation Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Bohui Innovation Red Blood Cell Products Product Portfolio Table 57. Bohui Innovation Recent Developments Table 58. Takeda Pharmaceutical Company Information Table 59. Takeda Pharmaceutical Business Overview Table 60. Takeda Pharmaceutical Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Takeda Pharmaceutical Red Blood Cell Products Product Portfolio Table 62. Takeda Pharmaceutical Recent Developments Table 63. Sangamo Therapeutics Company Information Table 64. Sangamo Therapeutics Business Overview Table 65. Sangamo Therapeutics Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Sangamo Therapeutics Red Blood Cell Products Product Portfolio Table 67. Sangamo Therapeutics Recent Developments Table 68. Octapharma Company Information Table 69. Octapharma Business Overview Table 70. Octapharma Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Octapharma Red Blood Cell Products Product Portfolio Table 72. Octapharma Recent Developments Table 73. LFB Group Company Information Table 74. LFB Group Business Overview Table 75. LFB Group Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. LFB Group Red Blood Cell Products Product Portfolio Table 77. LFB Group Recent Developments Table 78. Kedrion Company Information Table 79. Kedrion Business Overview Table 80. Kedrion Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Kedrion Red Blood Cell Products Product Portfolio Table 82. Kedrion Recent Developments Table 83. Kamada Company Information Table 84. Kamada Business Overview Table 85. Kamada Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Kamada Red Blood Cell Products Product Portfolio Table 87. Kamada Recent Developments Table 88. Hemophilia Federation Europe Company Information Table 89. Hemophilia Federation Europe Business Overview Table 90. Hemophilia Federation Europe Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Hemophilia Federation Europe Red Blood Cell Products Product Portfolio Table 92. Hemophilia Federation Europe Recent Developments Table 93. Grifols Company Information Table 94. Grifols Business Overview Table 95. Grifols Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Grifols Red Blood Cell Products Product Portfolio Table 97. Grifols Recent Developments Table 98. Emergent BioSolutions Company Information Table 99. Emergent BioSolutions Business Overview Table 100. Emergent BioSolutions Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Emergent BioSolutions Red Blood Cell Products Product Portfolio Table 102. Emergent BioSolutions Recent Developments Table 103. CSL Behring Company Information Table 104. CSL Behring Business Overview Table 105. CSL Behring Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. CSL Behring Red Blood Cell Products Product Portfolio Table 107. CSL Behring Recent Developments Table 108. Biotest Company Information Table 109. Biotest Business Overview Table 110. Biotest Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Biotest Red Blood Cell Products Product Portfolio Table 112. Biotest Recent Developments Table 113. American Red Cross Company Information Table 114. American Red Cross Business Overview Table 115. American Red Cross Red Blood Cell Products Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. American Red Cross Red Blood Cell Products Product Portfolio Table 117. American Red Cross Recent Developments Table 118. Global Red Blood Cell Products Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Red Blood Cell Products Sales by Region (2021-2026) & (units) Table 120. Global Red Blood Cell Products Sales Market Share by Region (2021-2026) Table 121. Global Red Blood Cell Products Sales by Region (2027-2032) & (units) Table 122. Global Red Blood Cell Products Sales Market Share by Region (2027-2032) Table 123. Global Red Blood Cell Products Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Red Blood Cell Products Revenue Market Share by Region (2021-2026) Table 125. Global Red Blood Cell Products Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Red Blood Cell Products Revenue Market Share by Region (2027-2032) Table 127. North America Red Blood Cell Products Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 129. North America Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 130. North America Red Blood Cell Products Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Red Blood Cell Products Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Red Blood Cell Products Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 134. Europe Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 135. Europe Red Blood Cell Products Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Red Blood Cell Products Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Red Blood Cell Products Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 139. Asia Pacific Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 140. Asia Pacific Red Blood Cell Products Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Red Blood Cell Products Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Red Blood Cell Products Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 144. South America Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 145. South America Red Blood Cell Products Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Red Blood Cell Products Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Red Blood Cell Products Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 149. Middle East and Africa Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 150. Middle East and Africa Red Blood Cell Products Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Red Blood Cell Products Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Red Blood Cell Products Sales by Type (2021-2026) & (units) Table 153. Global Red Blood Cell Products Sales by Type (2027-2032) & (units) Table 154. Global Red Blood Cell Products Sales Market Share by Type (2021-2026) Table 155. Global Red Blood Cell Products Sales Market Share by Type (2027-2032) Table 156. Global Red Blood Cell Products Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Red Blood Cell Products Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Red Blood Cell Products Revenue Market Share by Type (2021-2026) Table 159. Global Red Blood Cell Products Revenue Market Share by Type (2027-2032) Table 160. Global Red Blood Cell Products Price by Type (2021-2026) & (USD/unit) Table 161. Global Red Blood Cell Products Price by Type (2027-2032) & (USD/unit) Table 162. Global Red Blood Cell Products Sales by Application (2021-2026) & (units) Table 163. Global Red Blood Cell Products Sales by Application (2027-2032) & (units) Table 164. Global Red Blood Cell Products Sales Market Share by Application (2021-2026) Table 165. Global Red Blood Cell Products Sales Market Share by Application (2027-2032) Table 166. Global Red Blood Cell Products Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Red Blood Cell Products Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Red Blood Cell Products Revenue Market Share by Application (2021-2026) Table 169. Global Red Blood Cell Products Revenue Market Share by Application (2027-2032) Table 170. Global Red Blood Cell Products Price by Application (2021-2026) & (USD/unit) Table 171. Global Red Blood Cell Products Price by Application (2027-2032) & (USD/unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Red Blood Cell Products Distributors List Table 175. Red Blood Cell Products Customers List Table 176. Red Blood Cell Products Industry Trends Table 177. Red Blood Cell Products Industry Drivers Table 178. Red Blood Cell Products Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Red Blood Cell Products Product Image Figure 5. Global Red Blood Cell Products Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Red Blood Cell Products Market Size (2021-2032) & (US$ Million) Figure 7. Global Red Blood Cell Products Sales (2021-2032) & (units) Figure 8. Global Red Blood Cell Products Average Price (USD/unit) & (2021-2032) Figure 9. Washed Red Blood Cells Product Image Figure 10. Concentrated Red Blood Cells Product Image Figure 11. Frozen Red Blood Cells Product Image Figure 12. Red Blood Cell Suspension Product Image Figure 13. Irradiated Red Blood Cells Product Image Figure 14. Others Product Image Figure 15. Blood Disease Supportive Treatment Product Image Figure 16. Special Disease Management Product Image Figure 17. Anemia Treatment Product Image Figure 18. Acute Hemorrhage Product Image Figure 19. Global Red Blood Cell Products Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Red Blood Cell Products, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Red Blood Cell Products Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Red Blood Cell Products Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Red Blood Cell Products Sales by Region in 2025 Figure 25. Global Red Blood Cell Products Revenue by Region in 2025 Figure 26. North America Red Blood Cell Products Market Size by Country in 2025 Figure 27. North America Red Blood Cell Products Sales Market Share by Country (2021-2032) Figure 28. North America Red Blood Cell Products Revenue Market Share by Country (2021-2032) Figure 29. United States Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Mexico Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Red Blood Cell Products Market Size by Country in 2025 Figure 33. Europe Red Blood Cell Products Sales Market Share by Country (2021-2032) Figure 34. Europe Red Blood Cell Products Revenue Market Share by Country (2021-2032) Figure 35. Germany Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Russia Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Spain Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Netherlands Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Switzerland Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Sweden Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Poland Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Asia Pacific Red Blood Cell Products Market Size by Country in 2025 Figure 46. Asia Pacific Red Blood Cell Products Sales Market Share by Country (2021-2032) Figure 47. Asia Pacific Red Blood Cell Products Revenue Market Share by Country (2021-2032) Figure 48. China Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Japan Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South Korea Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. India Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Australia Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Taiwan Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. South America Red Blood Cell Products Market Size by Country in 2025 Figure 57. South America Red Blood Cell Products Sales Market Share by Country (2021-2032) Figure 58. South America Red Blood Cell Products Revenue Market Share by Country (2021-2032) Figure 59. Brazil Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Argentina Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Chile Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Middle East and Africa Red Blood Cell Products Market Size by Country in 2025 Figure 63. Middle East and Africa Red Blood Cell Products Sales Market Share by Country (2021-2032) Figure 64. Middle East and Africa Red Blood Cell Products Revenue Market Share by Country (2021-2032) Figure 65. Egypt Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. South Africa Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Israel Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Türkiye Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. GCC Countries Red Blood Cell Products Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Global Red Blood Cell Products Sales Market Share by Type (2021-2032) Figure 71. Global Red Blood Cell Products Revenue Market Share by Type (2021-2032) Figure 72. Global Red Blood Cell Products Price (USD/unit) by Type (2021-2032) Figure 73. Global Red Blood Cell Products Sales Market Share by Application (2021-2032) Figure 74. Global Red Blood Cell Products Revenue Market Share by Application (2021-2032) Figure 75. Global Red Blood Cell Products Price (USD/unit) by Application (2021-2032) Figure 76. Red Blood Cell Products Value Chain Figure 77. Red Blood Cell Products Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Red Blood Cell Products Industry Opportunities and Challenges

Scope & coverage.

Types
  • Washed Red Blood Cells
  • Concentrated Red Blood Cells
  • Frozen Red Blood Cells
  • Red Blood Cell Suspension
  • Irradiated Red Blood Cells
  • Others
Applications
  • Blood Disease Supportive Treatment
  • Special Disease Management
  • Anemia Treatment
  • Acute Hemorrhage
Companies covered
  • China National Biotec Group
  • Weiguang Biological
  • Tiantan Biological
  • Shanghai RAAS Blood Products
  • Pilin Biological
  • Hualan Biological
  • Boyaa Bio-pharmaceutical
  • Bohui Innovation
  • Takeda Pharmaceutical
  • Sangamo Therapeutics
  • Octapharma
  • LFB Group
  • Kedrion
  • Kamada
  • Hemophilia Federation Europe
  • Grifols
  • Emergent BioSolutions
  • CSL Behring
  • Biotest
  • American Red Cross

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Red Blood Cell Products Market Size (2021-2032)
  4. 2.2.2 Global Red Blood Cell Products Sales (2021-2032)
  5. 2.2.3 Global Red Blood Cell Products Market Average Price (2021-2032)
  6. 2.3 Red Blood Cell Products by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Washed Red Blood Cells
  9. 2.3.3 Concentrated Red Blood Cells
  10. 2.3.4 Frozen Red Blood Cells
  11. 2.3.5 Red Blood Cell Suspension
  12. 2.3.6 Irradiated Red Blood Cells
  13. 2.3.7 Others
  14. 2.4 Red Blood Cell Products by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Blood Disease Supportive Treatment
  17. 2.4.3 Special Disease Management
  18. 2.4.4 Anemia Treatment
  19. 2.4.5 Acute Hemorrhage
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Red Blood Cell Products Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Red Blood Cell Products Sales (units) of Manufacturers (2021-2026)
  3. 3.3 Global Red Blood Cell Products Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Red Blood Cell Products Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Red Blood Cell Products Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Red Blood Cell Products, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Red Blood Cell Products, Product Type & Application
  8. 3.8 Global Manufacturers of Red Blood Cell Products, Established Date
  9. 3.9 Global Red Blood Cell Products Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 China National Biotec Group
  2. 4.1.1 China National Biotec Group Company Information
  3. 4.1.2 China National Biotec Group Business Overview
  4. 4.1.3 China National Biotec Group Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 China National Biotec Group Red Blood Cell Products Product Portfolio
  6. 4.1.5 China National Biotec Group Recent Developments
  7. 4.2 Weiguang Biological
  8. 4.2.1 Weiguang Biological Company Information
  9. 4.2.2 Weiguang Biological Business Overview
  10. 4.2.3 Weiguang Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Weiguang Biological Red Blood Cell Products Product Portfolio
  12. 4.2.5 Weiguang Biological Recent Developments
  13. 4.3 Tiantan Biological
  14. 4.3.1 Tiantan Biological Company Information
  15. 4.3.2 Tiantan Biological Business Overview
  16. 4.3.3 Tiantan Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Tiantan Biological Red Blood Cell Products Product Portfolio
  18. 4.3.5 Tiantan Biological Recent Developments
  19. 4.4 Shanghai RAAS Blood Products
  20. 4.4.1 Shanghai RAAS Blood Products Company Information
  21. 4.4.2 Shanghai RAAS Blood Products Business Overview
  22. 4.4.3 Shanghai RAAS Blood Products Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Shanghai RAAS Blood Products Red Blood Cell Products Product Portfolio
  24. 4.4.5 Shanghai RAAS Blood Products Recent Developments
  25. 4.5 Pilin Biological
  26. 4.5.1 Pilin Biological Company Information
  27. 4.5.2 Pilin Biological Business Overview
  28. 4.5.3 Pilin Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Pilin Biological Red Blood Cell Products Product Portfolio
  30. 4.5.5 Pilin Biological Recent Developments
  31. 4.6 Hualan Biological
  32. 4.6.1 Hualan Biological Company Information
  33. 4.6.2 Hualan Biological Business Overview
  34. 4.6.3 Hualan Biological Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Hualan Biological Red Blood Cell Products Product Portfolio
  36. 4.6.5 Hualan Biological Recent Developments
  37. 4.7 Boyaa Bio-pharmaceutical
  38. 4.7.1 Boyaa Bio-pharmaceutical Company Information
  39. 4.7.2 Boyaa Bio-pharmaceutical Business Overview
  40. 4.7.3 Boyaa Bio-pharmaceutical Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Boyaa Bio-pharmaceutical Red Blood Cell Products Product Portfolio
  42. 4.7.5 Boyaa Bio-pharmaceutical Recent Developments
  43. 4.8 Bohui Innovation
  44. 4.8.1 Bohui Innovation Company Information
  45. 4.8.2 Bohui Innovation Business Overview
  46. 4.8.3 Bohui Innovation Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Bohui Innovation Red Blood Cell Products Product Portfolio
  48. 4.8.5 Bohui Innovation Recent Developments
  49. 4.9 Takeda Pharmaceutical
  50. 4.9.1 Takeda Pharmaceutical Company Information
  51. 4.9.2 Takeda Pharmaceutical Business Overview
  52. 4.9.3 Takeda Pharmaceutical Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Takeda Pharmaceutical Red Blood Cell Products Product Portfolio
  54. 4.9.5 Takeda Pharmaceutical Recent Developments
  55. 4.10 Sangamo Therapeutics
  56. 4.10.1 Sangamo Therapeutics Company Information
  57. 4.10.2 Sangamo Therapeutics Business Overview
  58. 4.10.3 Sangamo Therapeutics Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sangamo Therapeutics Red Blood Cell Products Product Portfolio
  60. 4.10.5 Sangamo Therapeutics Recent Developments
  61. 4.11 Octapharma
  62. 4.11.1 Octapharma Company Information
  63. 4.11.2 Octapharma Business Overview
  64. 4.11.3 Octapharma Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Octapharma Red Blood Cell Products Product Portfolio
  66. 4.11.5 Octapharma Recent Developments
  67. 4.12 LFB Group
  68. 4.12.1 LFB Group Company Information
  69. 4.12.2 LFB Group Business Overview
  70. 4.12.3 LFB Group Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 LFB Group Red Blood Cell Products Product Portfolio
  72. 4.12.5 LFB Group Recent Developments
  73. 4.13 Kedrion
  74. 4.13.1 Kedrion Company Information
  75. 4.13.2 Kedrion Business Overview
  76. 4.13.3 Kedrion Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Kedrion Red Blood Cell Products Product Portfolio
  78. 4.13.5 Kedrion Recent Developments
  79. 4.14 Kamada
  80. 4.14.1 Kamada Company Information
  81. 4.14.2 Kamada Business Overview
  82. 4.14.3 Kamada Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Kamada Red Blood Cell Products Product Portfolio
  84. 4.14.5 Kamada Recent Developments
  85. 4.15 Hemophilia Federation Europe
  86. 4.15.1 Hemophilia Federation Europe Company Information
  87. 4.15.2 Hemophilia Federation Europe Business Overview
  88. 4.15.3 Hemophilia Federation Europe Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Hemophilia Federation Europe Red Blood Cell Products Product Portfolio
  90. 4.15.5 Hemophilia Federation Europe Recent Developments
  91. 4.16 Grifols
  92. 4.16.1 Grifols Company Information
  93. 4.16.2 Grifols Business Overview
  94. 4.16.3 Grifols Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Grifols Red Blood Cell Products Product Portfolio
  96. 4.16.5 Grifols Recent Developments
  97. 4.17 Emergent BioSolutions
  98. 4.17.1 Emergent BioSolutions Company Information
  99. 4.17.2 Emergent BioSolutions Business Overview
  100. 4.17.3 Emergent BioSolutions Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Emergent BioSolutions Red Blood Cell Products Product Portfolio
  102. 4.17.5 Emergent BioSolutions Recent Developments
  103. 4.18 CSL Behring
  104. 4.18.1 CSL Behring Company Information
  105. 4.18.2 CSL Behring Business Overview
  106. 4.18.3 CSL Behring Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 CSL Behring Red Blood Cell Products Product Portfolio
  108. 4.18.5 CSL Behring Recent Developments
  109. 4.19 Biotest
  110. 4.19.1 Biotest Company Information
  111. 4.19.2 Biotest Business Overview
  112. 4.19.3 Biotest Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Biotest Red Blood Cell Products Product Portfolio
  114. 4.19.5 Biotest Recent Developments
  115. 4.20 American Red Cross
  116. 4.20.1 American Red Cross Company Information
  117. 4.20.2 American Red Cross Business Overview
  118. 4.20.3 American Red Cross Red Blood Cell Products Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 American Red Cross Red Blood Cell Products Product Portfolio
  120. 4.20.5 American Red Cross Recent Developments
5 Global Red Blood Cell Products Market Scenario by Region
  1. 5.1 Global Red Blood Cell Products Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Red Blood Cell Products Sales by Region: 2021-2032
  3. 5.2.1 Global Red Blood Cell Products Sales by Region: 2021-2026
  4. 5.2.2 Global Red Blood Cell Products Sales by Region: 2027-2032
  5. 5.3 Global Red Blood Cell Products Revenue by Region: 2021-2032
  6. 5.3.1 Global Red Blood Cell Products Revenue by Region: 2021-2026
  7. 5.3.2 Global Red Blood Cell Products Revenue by Region: 2027-2032
  8. 5.4 North America Red Blood Cell Products Market Facts & Figures by Country
  9. 5.4.1 North America Red Blood Cell Products Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Red Blood Cell Products Sales by Country (2021-2032)
  11. 5.4.3 North America Red Blood Cell Products Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Red Blood Cell Products Market Facts & Figures by Country
  16. 5.5.1 Europe Red Blood Cell Products Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Red Blood Cell Products Sales by Country (2021-2032)
  18. 5.5.3 Europe Red Blood Cell Products Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Red Blood Cell Products Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Red Blood Cell Products Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Red Blood Cell Products Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Red Blood Cell Products Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Red Blood Cell Products Market Facts & Figures by Country
  41. 5.7.1 South America Red Blood Cell Products Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Red Blood Cell Products Sales by Country (2021-2032)
  43. 5.7.3 South America Red Blood Cell Products Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Red Blood Cell Products Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Red Blood Cell Products Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Red Blood Cell Products Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Red Blood Cell Products Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Red Blood Cell Products Sales by Type (2021-2032)
  2. 6.1.1 Global Red Blood Cell Products Sales by Type (2021-2032) & (units)
  3. 6.1.2 Global Red Blood Cell Products Sales Market Share by Type (2021-2032)
  4. 6.2 Global Red Blood Cell Products Revenue by Type (2021-2032)
  5. 6.2.1 Global Red Blood Cell Products Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Red Blood Cell Products Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Red Blood Cell Products Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Red Blood Cell Products Sales by Application (2021-2032)
  2. 7.1.1 Global Red Blood Cell Products Sales by Application (2021-2032) & (units)
  3. 7.1.2 Global Red Blood Cell Products Sales Market Share by Application (2021-2032)
  4. 7.2 Global Red Blood Cell Products Revenue by Application (2021-2032)
  5. 7.2.1 Global Red Blood Cell Products Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Red Blood Cell Products Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Red Blood Cell Products Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Red Blood Cell Products Value Chain Analysis
  2. 8.1.1 Red Blood Cell Products Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Red Blood Cell Products Production Mode & Process
  5. 8.2 Red Blood Cell Products Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Red Blood Cell Products Distributors
  8. 8.2.3 Red Blood Cell Products Customers
9 Global Red Blood Cell Products Analyzing Market Dynamics
  1. 9.1 Red Blood Cell Products Industry Trends
  2. 9.2 Red Blood Cell Products Industry Drivers
  3. 9.3 Red Blood Cell Products Industry Opportunities and Challenges
  4. 9.4 Red Blood Cell Products Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst